3/7
05:23 pm
cogt
Rating for COGT
Medium
Report
Rating for COGT
3/7
05:23 pm
cogt
Rating for COGT
Medium
Report
Rating for COGT
3/7
08:17 am
cogt
Cogent Biosciences, Inc. (NASDAQ: COGT) is now covered by analysts at Scotiabank. They set a "sector outperform" rating and a $17.00 price target on the stock.
Medium
Report
Cogent Biosciences, Inc. (NASDAQ: COGT) is now covered by analysts at Scotiabank. They set a "sector outperform" rating and a $17.00 price target on the stock.
3/7
08:17 am
cogt
Cogent Biosciences, Inc. (NASDAQ: COGT) is now covered by analysts at Scotiabank. They set a "sector outperform" rating and a $17.00 price target on the stock.
Medium
Report
Cogent Biosciences, Inc. (NASDAQ: COGT) is now covered by analysts at Scotiabank. They set a "sector outperform" rating and a $17.00 price target on the stock.
3/7
06:53 am
cogt
Cogent Biosciences initiated with an Outperform at Scotiabank
Medium
Report
Cogent Biosciences initiated with an Outperform at Scotiabank
3/7
06:53 am
cogt
Cogent Biosciences initiated with an Outperform at Scotiabank
Medium
Report
Cogent Biosciences initiated with an Outperform at Scotiabank
2/27
07:42 am
cogt
Rating for COGT
Low
Report
Rating for COGT
2/27
07:42 am
cogt
Rating for COGT
Low
Report
Rating for COGT
2/26
08:00 am
cogt
Cogent Biosciences, Inc. (NASDAQ: COGT) had its "hold" rating re-affirmed by analysts at Needham & Company LLC.
Medium
Report
Cogent Biosciences, Inc. (NASDAQ: COGT) had its "hold" rating re-affirmed by analysts at Needham & Company LLC.
2/26
06:15 am
cogt
Rating for COGT
Low
Report
Rating for COGT
2/26
06:15 am
cogt
Rating for COGT
Low
Report
Rating for COGT
2/25
12:14 pm
cogt
Cogent Biosciences, Inc. (NASDAQ: COGT) had its "neutral" rating re-affirmed by analysts at Wedbush. They now have a $11.00 price target on the stock.
Low
Report
Cogent Biosciences, Inc. (NASDAQ: COGT) had its "neutral" rating re-affirmed by analysts at Wedbush. They now have a $11.00 price target on the stock.
2/25
12:14 pm
cogt
Cogent Biosciences, Inc. (NASDAQ: COGT) had its "neutral" rating re-affirmed by analysts at Wedbush. They now have a $11.00 price target on the stock.
Low
Report
Cogent Biosciences, Inc. (NASDAQ: COGT) had its "neutral" rating re-affirmed by analysts at Wedbush. They now have a $11.00 price target on the stock.
1/13
06:17 pm
cogt
Cogent Biosciences, Inc. (NASDAQ: COGT) had its "neutral" rating re-affirmed by analysts at Wedbush. They now have a $11.00 price target on the stock.
Low
Report
Cogent Biosciences, Inc. (NASDAQ: COGT) had its "neutral" rating re-affirmed by analysts at Wedbush. They now have a $11.00 price target on the stock.
1/13
06:17 pm
cogt
Cogent Biosciences, Inc. (NASDAQ: COGT) had its "neutral" rating re-affirmed by analysts at Wedbush. They now have a $11.00 price target on the stock.
Low
Report
Cogent Biosciences, Inc. (NASDAQ: COGT) had its "neutral" rating re-affirmed by analysts at Wedbush. They now have a $11.00 price target on the stock.